SCHEMBL5243190

SCHEMBL5243190

NC(=O)[C@H](O)CN1CCCCC1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.54
KMT2A Q03164 1/20 0.54
ANPEP P15144 1/20 0.47
ERAP2 Q6P179 1/20 0.47
L3MBTL1 Q9Y468 1/20 0.47
HSD17B10 Q99714 1/20 0.46
MAPT P10636 4/20 0.45
ATM Q13315 2/20 0.45
ALDH1A1 P00352 3/20 0.42
HPGD P15428 1/20 0.42
GAA P10253 1/20 0.39
POLB P06746 1/20 0.39
CHRM2 P08172 1/20 0.38
ADRA2B P18089 1/20 0.38
DRD3 P35462 1/20 0.38
SIGMAR1 Q99720 1/20 0.38
HRH3 Q9Y5N1 1/20 0.38
PKM P14618 1/20 0.37
BCHE P06276 1/20 0.37
ACHE P22303 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19532370 1.00 MEN1 (0.54) MEN1KMT2AANPEPERAP2L3MBTL1
SCHEMBL5243859 0.98 MEN1 (0.50) MEN1KMT2AANPEPERAP2L3MBTL1
SCHEMBL5254183 0.98 MEN1 (0.50) MEN1KMT2AANPEPERAP2L3MBTL1
SCHEMBL472331 0.80 MEN1 (0.56) MEN1KMT2AANPEPERAP2L3MBTL1
SCHEMBL4489543 0.79 USP2 (0.57) MEN1KMT2AANPEPL3MBTL1HSD17B10
SCHEMBL21806105 0.79 SMN1; SMN2 (0.42) MEN1KMT2AANPEPERAP2HSD17B10
SCHEMBL4150403 0.79 USP2 (0.57) MEN1KMT2AANPEPL3MBTL1HSD17B10
SCHEMBL4637391 0.78 ANPEP (0.52) MEN1KMT2AANPEPERAP2L3MBTL1
SCHEMBL4486391 0.78 RAB9A (0.34) MEN1KMT2AALDH1A1CYP2C19LMNA
SCHEMBL21748901 0.77 CHRM2 (0.51) MEN1KMT2AANPEPERAP2L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1455777-B1 GLYT1 TRANSPORTER INHIBITORS AND USES THEREOF IN TREATMENT OF NEUROLOGICAL AND NEUROPSYCHIATRIC DISORDERS SMITHKLINE BEECHAM PLC (GB) 2007-11-21 EP claimed
EP-1455777-A1 GLYT1 TRANSPORTER INHIBITORS AND USES THEREOF IN TREATMENT OF NEUROLOGICAL AND NEUROPSYCHIATRIC DISORDERS SMITHKLINE BEECHAM PLC (GB) 2004-09-15 EP claimed
WO-2003055478-A1 GLYT1 TRANSPORTER INHIBITORS AND USES THEREOF IN TREATMENT OF NEUROLOGICAL AND NEUROPSYCHIATRIC DISORDERS SMITHKLINE BEECHAM P.L.C. (GB) 2003-07-10 WO claimed
EP-1455777-A1 GLYT1 TRANSPORTER INHIBITORS AND USES THEREOF IN TREATMENT OF NEUROLOGICAL AND NEUROPSYCHIATRIC DISORDERS SMITHKLINE BEECHAM PLC (GB) 2004-09-15 EP disclosed
WO-2003055478-A1 GLYT1 TRANSPORTER INHIBITORS AND USES THEREOF IN TREATMENT OF NEUROLOGICAL AND NEUROPSYCHIATRIC DISORDERS SMITHKLINE BEECHAM P.L.C. (GB) 2003-07-10 WO disclosed